Abcam PLC
LSE:ABC
Abcam PLC
LSE:ABC
Price:
1 226 GBX
11.15%
Updated:
May 15, 2024
Abcam PLC
Income from Continuing Operations
|
Abcam PLC
Income from Continuing Operations Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abcam PLC
LSE:ABC
|
Income from Continuing Operations
£6.8m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-12%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Income from Continuing Operations
-$151.1m
|
CAGR 3-Years
-142%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Income from Continuing Operations
-$208.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Income from Continuing Operations
-$168.2m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Income from Continuing Operations
-£55.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Income from Continuing Operations
£30.1m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
See Also
What is Abcam PLC's Income from Continuing Operations?
Income from Continuing Operations
6.8m
GBP
6.8m
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's Income from Continuing Operations amounts to 6.8m GBP.
What is Abcam PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-12%
-12%
Over the last year, the Income from Continuing Operations growth was -58%. The average annual Income from Continuing Operations growth rates for Abcam PLC have been -47% over the past three years , -31% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
